More about
Drug-Resistant Mesial Temporal Lobe Epilepsy
News
June 21, 2024
1 min read
Save
FDA grants Regenerative Medicine Advanced Therapy designation to epilepsy treatment
The FDA has granted Regenerative Medicine Advanced Therapy designation to a novel regenerative cell therapy to treat drug-resistant mesial temporal lobe epilepsy, according to the manufacturer.